Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapital & Regional Regulatory News (CAL)

  • This share is currently suspended. It was suspended at a price of 62.40
  • There is currently no data for CAL

Director/PDMR Shareholding

29 Jun 2020 16:30

RNS Number : 4249R
Capital & Regional plc
29 June 2020
 

 

29 June 2020

 

CAPITAL & REGIONAL PLC ("Capital & Regional" or "the Company")

UK company number 01399411

LSE share code: CAL

ISIN: GB00BL6XZ716

LEI: 21380097W74N9OYF5Z25

 

DIRECTOR SHAREHOLDINGS

 

The Company has received notification of the following transactions involving the acquisition of ordinary shares of 10 pence each ("Shares") in the Company on 24 June 2020 through the Company's Scrip Dividend Scheme ("the Scrip"). The Shares were acquired on the London Stock Exchange at 91.00 pence per share, being the Scrip reference share price.

 

Beneficial holder

Position

Number of Shares acquired through the Scrip

Total Shares in which an interest is held following the issue of new shares

Lawrence Hutchings

Executive Director

538

6,105

Stuart Wetherly

Executive Director

1,885

22,174

David Hunter

Chairman

6,285

71,285

Tony Hales

Non-Executive Director

3,991

45,265

Ian Krieger

Non-Executive Director

1,015

11,515

Laura Whyte

Non-Executive Director

531

27,029

 

 

 

 

Shareholdings connected to Louis Norval:

Non-Executive Director

 

 

PDI Investment Holdings Limited

 

400,018

4,536,568

MStead Limited

 

506,313

5,742,052

 

 

 

 

Shareholdings connected to Norbert Sasse:

Non-Executive Director

 

 

Janine Sasse

 

3,707

42,042

 

 

 

 

 

The shares acquired through the scrip by PDI Investment Holdings Limited and Mstead Limited have been added to the shares already subject to a pledge in respect of investment arrangements, resulting in the total shareholdings of 4,536,568 and 5,742,052 respectively being subject to the pledge.

 

The revised beneficial interest of Louis Norval and his family members in ordinary shares of the Company is 10,313,718 shares, representing 9.22% of the Company's issued share capital.

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation.

 

- ENDS -

 

For further information:

 

Capital & Regional

Lawrence Hutchings, Chief Executive OfficerStuart Wetherly, Group Finance Director

 

+ 44 (0) 20 7932 8000

FTI Consulting

Richard Sunderland

Methuselah Tanyanyiwa

Claire Turvey

capreg@fticonsulting.com

 

+ 44 (0) 20 3727 1000

About Capital & Regional plc

Capital & Regional is a UK focused specialist property REIT with a strong track record of delivering significant value enhancing retail and leisure asset management opportunities across its portfolio of in-town, dominant community shopping centres.

 

Capital & Regional owns seven shopping centres in Blackburn, Hemel Hempstead, Ilford, Luton, Maidstone, Walthamstow and Wood Green. Capital & Regional manages these assets through its in-house expert property and asset management platform.

 

For further information see www.capreg.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFLERDIAFII
Date   Source Headline
30th Apr 20247:00 amRNSFull Year Results to 30 December 2023
22nd Apr 20247:01 amRNSAppointment of Non-Executive Director
22nd Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSDividend Finalisation Announcement
11th Mar 20249:30 amRNSBoard Notification
8th Mar 20247:00 amRNSUpdate on Year End results
8th Feb 20241:00 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSChange of Adviser
10th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 20231:00 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSAcquisition of shares by Employee Share Trust
14th Sep 202311:15 amRNSHolding(s) in Company
13th Sep 20237:00 amRNSResults of Scrip Dividend Election
7th Sep 20233:00 pmRNSHolding(s) in Company
25th Aug 20237:00 amRNSResult of Open Offer
22nd Aug 202310:00 amRNSDividend Finalisation Announcement
10th Aug 20232:05 pmRNSPublication of Prospectus
10th Aug 20239:00 amRNSBoard Notification
10th Aug 20237:01 amRNSHalf Year Results to 30 June 2023
10th Aug 20237:00 amRNSAcquisition and Launch of Open Offer
24th Jul 20239:30 amRNSNOTICE OF HALF YEAR RESULTS – UPDATED TIMINGS
24th Jul 20237:00 amRNSNotice of Half Year Results
7th Jun 20237:00 amRNSDirector Shareholding
25th May 20232:02 pmRNSResults of Scrip dividend election
25th May 20232:01 pmRNSChange of Auditor
25th May 20232:00 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Trading Update
16th May 20232:45 pmRNSHolding(s) in Company
2nd May 20234:00 pmRNSCombined Incentive Plan award
28th Apr 20234:04 pmRNSNotice of AGM and publication of Annual Report
24th Apr 20234:15 pmRNSResults of Scrip Dividend Election
31st Mar 202310:00 amRNSDividend Finalisation Announcement
17th Mar 20237:00 amRNSDisposal of The Mall, Luton
2nd Mar 20237:00 amRNSFull Year Results to 30 December 2022
1st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 202312:00 pmRNSBoard Notification
20th Feb 20237:00 amRNSAppointment of Director
14th Feb 20237:00 amRNSNotice of 2022 Full Year Results
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 20224:35 pmRNSPrice Monitoring Extension
7th Dec 20222:00 pmRNSUpdate on Trading and Property Portfolio
16th Nov 202211:00 amRNSChange of Auditor
5th Oct 20224:00 pmRNSTotal Voting Rights
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
26th Sep 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.